Atlas Trials

Open-Label Study of INO-4212 With or Without INO-9012, Administered IM or ID Followed by Electroporation in Healthy Volunteers

Clinical trial NCT02464670 · COMPLETED

Trial details

NCT number
NCT02464670
Sponsor
Inovio Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Ebola Vaccine
Start date
2015-05-01
Primary completion
2018-05-24
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.